Natural Killer (nk) Cells - Pharma

Relevant Publications

Dietary vitamin D supplementation enhances splenic NK cell activity in healthy and diabetic male mice.

Issue Release: 2024

BCG priming followed by a novel interleukin combination activates Natural Killer cells to selectively proliferate and become anti-tumour long-lived effectors.

Issue Release: 2024

Developing oxaliplatin and IL-15 Co-carried gels as drug depots to enable triple-interlocked combination therapy for colorectal cancer.

Issue Release: 2024

A model of dysregulated crosstalk between dendritic, natural killer, and regulatory T cells in chronic obstructive pulmonary disease.

Issue Release: 2024

Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplification.

Issue Release: 2024

Hippo kinases Mst1 and Mst2 maintain NK cell homeostasis by orchestrating metabolic state and transcriptional activity.

Issue Release: 2024

SIRT2 as a Potential Biomarker in Lung Adenocarcinoma: Implications for Immune Infiltration.

Issue Release: 2024

CREB1 promotes expression of immune checkpoint HLA-E leading to immune escape in multiple myeloma.

Issue Release: 2024

DOT1L maintains NK cell phenotype and function for optimal tumor control.

Issue Release: 2024

KPC-luciferase-expressing cells elicit an anti-tumor immune response in a mouse model of pancreatic cancer.

Issue Release: 2024

Biosynthetic MnSe Nanobomb with Low Mn Content Activates the cGAS-STING Pathway and Induces Immunogenic Cell Death to Enhance Antitumour Immunity.

Issue Release: 2024

Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer.

Issue Release: 2024

Interconnected lineage trajectories link conventional and natural killer (NK)-like exhausted CD8 T cells beneficial in type 1 diabetes.

Issue Release: 2024

The HHV-6B U20 glycoprotein binds ULBP1, masking it from recognition by NKG2D and interfering with natural killer cell activation.

Issue Release: 2024

IFNγ mediates the resistance of tumor cells to distinct NK cell subsets.

Issue Release: 2024

Diversity of group 1 innate lymphoid cells in human tissues.

Issue Release: 2024

Unveiling the Significance of HLA and KIR Diversity in Underrepresented Populations.

Issue Release: 2024

An Improved Two-Shot Tracking Algorithm for Dynamics Analysis of Natural Killer Cells in Tumor Contexts.

Issue Release: 2024

History of Hemophagocytic Lymphohistiocytosis.

Issue Release: 2024

Distinct granzyme k expression in immune cells: a single-cell rna-seq meta-analysis.

Issue Release: 2024

What is Regulatory Approval?

Why are Collaborative Care Models Important in Pharma?

What Causes Adverse Drug Events?

What Are Clinical Trials?

Why is the Management of Chronic Conditions Important?

What Challenges Exist in Patient Education?

What Strategies do Brand-Name Companies Use to Delay Generic Entry?

What are the Benefits of Collaborative Care Models?

What is Transitional Care?

What Are the Challenges of Clinical Trials?

Partnered Content Networks

Relevant Topics